osteosarcoma cell line osa c1 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
95
Structured Review
ATCC
osteosarcoma cell line osa c1
Osteosarcoma Cell Line Osa C1, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 369 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/osteosarcoma+cell+line+osa+c1/c1/pm11518050-58-1-5
Average 95 stars, based on 369 article reviews
Osteosarcoma Cell Line Osa C1, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 369 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/osteosarcoma+cell+line+osa+c1/c1/pm11518050-58-1-5
Average 95 stars, based on 369 article reviews
osteosarcoma cell line osa c1 - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Amplification:Article Title: Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literature. Article Snippet: We investigated a lipoma and a well-differentiated/dedifferentiated liposarcoma (WD/DDL), occurring simultaneously in one patient for the possible role of p53 and mdm2 in the molecular oncogenesis of liposarcoma and tumor progression.. The hypothesis tested was if there is a continuum in the development from lipoma to liposarcoma.. Lipoma was characterized by a lack of p53 mutation, p53 LOH and p53 protein expression, as well as by mdm2 amplification and mdm2 protein expression. p53 mutation and p53 LOH were found neither in the well-differentiated nor in the dedifferentiated parts of the liposarcoma. Positive Control:Article Title: Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literature. Article Snippet: We investigated a lipoma and a well-differentiated/dedifferentiated liposarcoma (WD/DDL), occurring simultaneously in one patient for the possible role of p53 and mdm2 in the molecular oncogenesis of liposarcoma and tumor progression.. The hypothesis tested was if there is a continuum in the development from lipoma to liposarcoma.. Lipoma was characterized by a lack of p53 mutation, p53 LOH and p53 protein expression, as well as by mdm2 amplification and mdm2 protein expression. p53 mutation and p53 LOH were found neither in the well-differentiated nor in the dedifferentiated parts of the liposarcoma. |